The results illustrated that c-Met deletion decreased tumor volume (Supplemental Figure 1I), tumor size (Supplemental Figure 1J), and tumor weight (Supplemental Figure 1K), and these effects were further enhanced after treatment with osimertinib (Figure 1, I and J, and Supplemental Figure 2C). Here, MET is linked to neoplasm.